The evidence behind StrydAR
See real patient outcomes and clinical effectiveness data.
Clinical
Results & Studies
StrydAR’s results are backed by extensive clinical research and real-world data from users with Parkinson's. Here’s what science says about our visual cueing approach.
Users report significant improvement
75%
Average time to notice changes
Instant
Report no medication conflicts
100%
Studies
The neurological bypass effect utilized by StrydAR is grounded in clinical trials demonstrating the immediate efficacy of visual cueing for Parkinson's disease gait.
Robert Gordon University (RGU) Clinical Trial
An independent clinical trial conducted to assess the immediate and measurable effects of the StrydAR wearable visual cueing device on the gait parameters of patients living with Parkinson's disease.
During the assessment, patients walking with the StrydAR continuous visual cue demonstrated statistically significant improvements in mean stride length, walking velocity, and a marked reduction in the frequency of Freezing of Gait (FOG) episodes compared to walking without the device.
Conducted by Robert Gordon University (RGU)
The foundational efficacy of visual cueing on Parkinsonian gait
Building upon decades of established neurological research, this foundational concept demonstrates why transitioning clinical visual cueing into wearable smart glasses allows patients to utilize cueing outside of controlled environments.
Studies show that high-contrast visual cues actively shift the brain's motor control from the impaired basal ganglia to the goal-directed visual cortex, proving to be a highly effective non-pharmacological intervention for mobility support.
Supported by broad consensus in Neurological Physiotherapy Practices
Recognised as a breakthrough innovation
Highlighted by STV News as a significant development in Parkinson's support, this feature showcases the clinical pilot study at Robert Gordon University (RGU) and the real-world impact of our visual cueing technology.
Award-winning technology
Winner of the Scottish Edge Innovation Award 2022
Less freezing
70-80% reported reduction in freezing
Freezing of Gait (FOG) occurs when the basal ganglia's automatic motor signals are blocked. By providing a clear visual target, StrydAR activates the visual cortex—bypassing the damaged pathways and allowing the brain to initiate goal-directed, conscious movement instead.
Improved posture
Users stand taller and walk more naturally
Traditional visual cues, such as tape on the floor, force the user to look down—exacerbating a hunched posture. StrydAR projects the cue into the upper peripheral vision, naturally encouraging the user to lift their head, straighten their back, and improve overall balance.
More confident walking
Users feel more confident leaving the house
Anxiety is a powerful trigger for freezing episodes. Having a continuous, on-demand visual cue breaks this cycle. It provides the cognitive reassurance and the physical tool needed to navigate spaces smoothly, restoring the independence and confidence to walk in public spaces.
Reduced reliance on aids
Less dependence on external walking aids
Standard walking frames only provide passive physical stability. By actively engaging and treating the neurological root of the gait impairment through visual stimulation, StrydAR allows many users to walk more fluidly without relying heavily on physical aids.
Recommended by
clinical specialists
"People felt the fluidity of their walking had improved, they felt more confident walking, and walked with a more even stride length, so they felt more confident and could walk faster with an improved quality, whereas other people felt it improved their posture and balance.”
Dr Julie Jones
Associate Professor & Chartered Physiotherapist (RGU)
"I have seen improvements in walking pattern, balance, posture and confidence in almost all of my clients who have tried them."
Amanda Mohar
Specialist long term conditions physio (HCPC 60169)